Beneficial effects of Control-IQ automated insulin delivery in basal-bolus and basal-only insulin users with type 2 diabetes

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works

On the adaptive control of the false discovery rate in multiple testing with independent statistics

Benjamini, Y., & Hochberg, Y. (2000) · Journal of Educational and Behavioral Statistics · doi:10.3102/10769986025001060 · Cited by 1,349 · see citing works

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030 · see citing works

Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes

Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644 · see citing works

Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes

Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585 · see citing works

Insulin‐associated weight gain in diabetes – causes, effects and coping strategies

Russell-Jones, D. L., & Khan, R. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00686.x · Cited by 556 · see citing works

A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence

Dias-Barbosa, C., Balp, Kulich, K. R., Germain, N., & Rofail, D. (2012) · Patient Preference and Adherence · doi:10.2147/ppa.s24752 · Cited by 549 · see citing works

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

Breton, M. D., Kanapka, L. G., Beck, R. W., Ekhlaspour, L., Forlenza, G. P., Cengiz, E., Schoelwer, M., Ruedy, K. J., Jost, E., Carria, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004736 · Cited by 455 · see citing works

Determining what individual SUS scores mean

(2009) · Journal of Usability Studies archive · doi:10.5555/2835587.2835589 · Cited by 412 · see citing works

Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes

Brown, S. A., Forlenza, G. P., Bode, B. W., Pinsker, J. E., Levy, C. J., Criego, A. B., Hansen, D. W., Hirsch, I. B., Carlson, A. L., Bergenstal, R. M., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0172 · Cited by 286 · see citing works

One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology

Breton, M. D., & Kovatchev, B. P. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0097 · Cited by 250 · see citing works

Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes

Forlenza, G. P., Pinhas‐Hamiel, O., Liljenquist, D. R., Shulman, D. I., Bailey, T. S., Bode, B. W., Wood, M. A., Buckingham, B. A., Kaiserman, K. B., Shin, J., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0264 · Cited by 182 · see citing works

Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial

Boughton, C. K., Tripyla, A., Hartnell, S., DALY, A. B., Herzig, D., Wilinska, M. E., Czerlau, C., Fry, A. C., Bally, L., & Hovorka, R. (2021) · Nature Medicine · doi:10.1038/s41591-021-01453-z · Cited by 126 · see citing works

Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial

Daly, A. B., Boughton, C. K., Nwokolo, M., Hartnell, S., Wilinska, M. E., Cezar, A., Evans, M. L., & Hovorka, R. (2023) · Nature Medicine · doi:10.1038/s41591-022-02144-z · Cited by 120 · see citing works

A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72

Beck, R. W., Kanapka, L., Breton, M. D., Brown, S. A., Wadwa, R., Buckingham, B. A., Kollman, C., & Kovatchev, B. P. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0558 · Cited by 102 · see citing works

Current Status and Emerging Options for Automated Insulin Delivery Systems

Forlenza, G. P., & Lal, R. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0514 · Cited by 70 · see citing works

Real-world evidence supporting Tandem Control-IQ hybrid closed-loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations

Forlenza, G. P., Carlson, A. L., Galindo, R. J., Kruger, D. F., Levy, C. J., McGill, J. B., Umpierrez, G., & Aleppo, G. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0206 · Cited by 70 · see citing works

710-P: Real-World Evaluation of Glycemic Outcomes by Prior Therapy for People with Type 1 and Type 2 Diabetes Onboarding to Control-IQ Technology

MORBERG, J. W., Singh, H., McElwee-Malloy, M., HABIF, S., & CONSTANTIN, A. (2021) · Diabetes · doi:10.2337/db21-710-p · Cited by 1 · see citing works

7. Diabetes Technology: Standards of Care in Diabetes—2025

American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348 · see citing works

The role of automated insulin delivery technology in diabetes

Boughton, C. K., & Hovorka, R. (2024) · Diabetologia · doi:10.1007/s00125-024-06165-w · Cited by 57 · see citing works

Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The <scp>CLOSE AP</scp> + randomized controlled trial

Reznik, Y., Carvalho, M., Fendri, S., Prevost, G., Chaillous, L., Riveline, J. P., Hanaire, H., Dubois, S., Houéto, P., Pasche, H., et al. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15351 · Cited by 34 · see citing works

Toward Automated Insulin Delivery

Bruttomesso, D. (2019) · New England Journal of Medicine · doi:10.1056/nejme1912822 · Cited by 11 · see citing works

The Predictive Low Glucose Management System in Prevention of Clinically Significant Hypoglycemia in Type 1 Diabetes. A Preliminary Study Identifying the Most Common Events Leading Up to Hypoglycemia During Insulin Pump Therapy

Thomakos, P., Mitrakou, A., Kepaptsoglou, O., Taraoune, I., Barreto, C., & Zoupas, C. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0889-7598 · Cited by 4 · see citing works

Adherence to Insulin Pump Behaviors in Young Children With Type 1 Diabetes Mellitus

Patton, S. R., Driscoll, K. A., & Clements, M. A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816658901 · Cited by 28 · see citing works

Clinical factors affecting the perception of hypoglycemia in type 1 diabetes patients treated with personal insulin pumps.

Matejko, B., Grzanka, M., Kieć‐Wilk, B., Malecki, M. T., & Klupa, T. (2013) · PubMed · Cited by 7 · see citing works

Hypoglycemic Coma Associated with Subcutaneous Insulin Infusion by Portable Pump

Lock, D. R., & Rigg, L. A. (1981) · Diabetes Care · doi:10.2337/diacare.4.3.389 · Cited by 34 · see citing works